Advertisement
(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
As a research-driven and customer-focused company, WuXi PharmaTechprovides drug R&D outsourcing services to 80 global pharmaceutical andbiotechnology companies. The company's value chain is partially supported bya large number of qualified suppliers who provide WuXi PharmaTech with top-quality equipment and instruments, raw materials, reagents, consumables andother related products and services. The conference, with a theme of "SupportPartner Success", awarded suppliers who have helped WuXi PharmaTech to achievegreater efficiency and cost savings; it also provided a great venue toexchange ideas and new supply chain strategies that can positively impactfinancial and operational performance of WuXi PharmaTech. The half-dayconference brought together about 120 representatives from over 70 selectedsupplier partners.
Advertisement
"The main purpose of WuXi PharmaTech's supplier conference is to promoteefficient, value-added supplier relationships with the collaborative partnersthat are fully aligned with our corporate values and business objectives. Wealso want our suppliers to better understand our unique business and operationmodel so that we can have the most efficient supply chain that is critical toimproving our service quality and keeping our competitive advantage. With ourrecent acquisition of AppTec, a US-based biologics testing and manufacturingservice company, WuXi PharmaTech will expand global sourcing operation andleverage global resources to further augment our service capability andcapacity." commented Dr. Ge Li, Chairman and Chief Executive Officer of WuXiPharmaTech.
To recognize suppliers who have made remarkable contributions to thesuccess of WuXi PharmaTech, the company presented Preferred Supplier Award toSigma-Aldrich and Alfa Aesar for their excellent services and products.Suppliers are evaluated on quality of management system, quality of products,on-time delivery, customer service and cost.
"We are greatly honored to receive this award from WuXi PharmaTech, theleading and the largest drug R&D service company in China. Most of WuXi'scustomers are also our customers and our vision 'Enabling Science Globallythrough Innovation' is consistent with that of WuXi's 'Transform Drug R&DGlobally'," commented Mr. Wilson Wang, Managing Director, Sigma-AldrichGreater China after the conference, "We are very happy to become one of WuXiPharmaTech's reliable partners."
"I would like to thank WuXi PharmaTech for presenting this award to us. Asa leading international manufacturer, supplier and distributor of finechemicals, metals, and materials, we will continue to raise the levels ofintegrity, quality, and professionalism in providing our products and servicesto WuXi PharmaTech and assist it in achieving its strategic goal," commentedMs. Deborah Groccott, General Manager, Avocado, UK of Alfa Aesar.
A Service Award was presented to Shanghai SILE to acknowledge its highlyproactive and responsive services to WuXi PharmaTech.
About WuXi PharmaTech
Founded in 2000, Shanghai-based WuXi PharmaTech is the leading China-basedpharmaceutical and biotechnology R&D outsourcing company. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceuticaland biotechnology companies with a broad and integrated portfolio oflaboratory and research manufacturing services throughout the drug discoveryand development process. WuXi PharmaTech's services are designed to assist itsglobal partners in shortening the cycle and lowering the cost of drugdiscovery and development by providing cost-effective and efficientoutsourcing solutions that save its cust
